Jump to navigation Jump to search
|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||147687.22 g·mol−1|
|(what is this?)|
Samalizumab is a humanized monoclonal antibody designed for oncology indications.
Samalizumab was developed by Alexion Pharmaceuticals.